Eagleville Hospital Methadone Induction Christine Falcone, RN, Director of Quality Management/Patient Safety Officer Charlie Folks, Director of Counseling.

Slides:

Advertisements

Similar presentations

Magnet Recognition Program®

Advertisements

Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.

Medication Management

1 NM Behavioral Health Collaborative New Mexico Behavioral Health Plan for Children, Youth and Their Families March 2007.

Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.

Provider Spring Meeting 2012 Sirrilla D. Blackmon, MSW, LCSW, LCAC Deputy Director Provider & Community Relations, Certification/Licensure Division of.

A Business Case for Quality: The Baltimore Experience ADAA Annual Management Conference October 2, 2008.

Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum MODULE 5 Take-Home Medication.

DMAS Office of Behavioral Health

Multi-Institutional Facilitated IRB Review Philip A. Cola, MA Vice President, Research and Technology University Hospitals Case Medical Center Third Annual.

Colorado Department of Healthcare Policy and FinancingColorado Department of Healthcare Policy and Financing Improving health care access and outcomes.

Buprenorphine Treatment: Care Coordination Indications and Options James Schuster, MD, MBA Chief Medical Officer Community Care.

Addiction Medicine Education, Patient Care and Research Update Alex Walley, MD, MSc Clinical Addiction Research and Education (CARE)

Introduction 3.03 Understand support services Introduction.

A Presentation By: E. Douglas Varney Commissioner, Department of Mental Health and Substance Abuse Services 9/27/2013.

PRE-CONFERENCE WORKSHOP FOR NEWCOMERS TO HPH May , Moscow Alberto Appicciafuoco Medical Director of Nuovo San Giovanni di Dio Hospital Florence,

Outpatient Services Programs Workgroup: Service Provision under Laura’s Law June 11, 2014.

Kristie R. Schmiege, MPH, CCS, CADC, CPC-M Director of Substance Abuse Services Genesee County Community Mental Health May 18,

Patient Centered Medical Home What it means for Duffy Health Center Board Presentation September 10 th 2012.

Memorial Hermann Healthcare System Clinical Integration & Disease Management Dan Wolterman April 15, 2010.

Participant Choice – Access to Recovery as a Voucher Service Delivery Model Presented to National Summit on Prisoner Re-Entry Sponsored by the White House.

1 Advancing Recovery: Baltimore Buprenorphine Initiative Tucson Presentation July 29, 2009 Baltimore Substance Abuse Systems.

January 25, 2011 Georgia Behavioral Health Caucus Community Care Joseph Bona, MD, MBA Chief Medical Officer DeKalb Community Service Board.

JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.

Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.

2015 HFAP Standards CMS Final Rule – Burden Reduction II May 2014 Karen Beem, MS, RN HFAP Standards Interpretation 2015 National Credentialing Forum1.

Maine Department of Health and Human Services Private Non-Medical Institutions (PNMI) Presentation to MaineCare Advisory Committee July 10, 2012

American Association for the Treatment of Opioid Dependence, Inc National Conference, Atlanta April 25, 2006 Evaluation of the Impact of Opioid Treatment.

Community Paramedic. Benchmark 101 We need a description of the epidemiology of the medical conditions targeted by the community paramedicine program.

Health Homes in Maryland Lisa Hadley, MD, JD March 29,

Addressing Co-Occurring Conditions: A Provider’s Perspective Joan E. Zweben, Ph.D. Executive Director: 14 th Street Clinic & EBCRP Clinical Professor of.

SCOPE OF PRACTICE: NURSING IN OHIO Pamela S. Dickerson, PhD, RN-BC, FAAN

Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.

Together.Today.Tomorrow. The BLUES Project Karen C. Fox, PhD Chief Executive Officer.

An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.

Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)

San Francisco County OBOT Pilot: Pharmacy Aspects Sharon Kotabe, PharmD Associate Administrator for Pharmaceutical Services Associate Clinical Professor.

LAWRENCE CAMPUS WEST 100 FEDERAL CITY ROAD LAWRENCEVILLE, NJ.

CROSS-SYSTEMS COLLABORATION INITIATIVE Helpful and Promising Practices for Service Providers Supporting Individuals with Intellectual/Developmental Disabilities.

Crystal Ball: QCSI Initiative. On 3/4/13, DMH Central Office chartered each of the 7 state psychiatric hospitals to develop one of the following: Treatment.

VANTAAN KAUPUNKI VANDA STAD Vantaa Detoxification Treatment Center -established only place in Vantaa that offers inpatient care specially for withdrawal.

MAT Funding Approaches Linda J. Frazier, RN, CHES, MA Treatment Manager Maine Office of Substance Abuse, DHHS.

The Troubled Physician Prevention and Intervention Anderson Spickard, Jr., M.D. Director Center for Professional Health at Vanderbilt December 20, 2002.

Guidance Training CFR §483.75(i) F501 Medical Director.

New Hanover Health Network Wilmington, North Carolina An Innovative Approach to Establishing Shared Governance Gabriele Pike, RN New Hanover Health Network.

TOWARDS RECOVERY CLINICS Patient Care. Community Fit. An Integrated Approach to Comprehensive Treatment.

United States Public Health Service -National Clinical Pharmacy Specialist (NCPS) Presentation prepared Presentation prepared by: CDR Anne Marie.

Nursing My specific job My specific job is a RN coordinator.

State of California Department of Alcohol and Drug Programs The Substance Abuse Research Consortium Semi Annual Meeting Improving the Quality, and Effectiveness.

ESSB 6656 Overview and Scope of the Select Committee on Quality Improvement in State Hospitals April 29, 2016 Kevin Black, Senate Committee Services Andy.

SUD Licensure Pennsylvania Department of Drug and Alcohol Programs Patricia De Leo.

CRISIS SERVICES FOR SUBSTANCE USE DISORDERS KEN BACHRACH, PH.D., CLINICAL DIRECTOR TARZANA TREATMENT CENTERS

For Official Use Only-I1-A1

FADAA Health Care Reform

3.03 Understand support services Introduction

San Francisco County OBOT Pilot: Pharmacy Aspects

Clinical Engineering Lecture (3).

Leaning Out the Nursing Policy and Procedure Process

3.03 Understand support services Introduction

3.03 Understand support services Introduction

Recovery Residences - Florida

Opioid Use Disorder Performance Incentive Criteria

GHS Medical Staff Appointments and Reappointments

3.03 Understand support services Introduction

3.03 Understand support services Introduction

Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.

Marie Crosson, Executive Director

Joint Powers Agreement

3.03 Understand support services Introduction

3.03 Understand support services Introduction

Presentation transcript:

Eagleville Hospital Methadone Induction Christine Falcone, RN, Director of Quality Management/Patient Safety Officer Charlie Folks, Director of Counseling and Community Integration

Methadone Utilization at Eagleville Hospital  Opiate Detoxification  Induction of Methadone Maintenance for Pregnant Females  Detoxification from other substances for Methadone Maintenance Patients  Rehabilitation of Methadone Maintenance Patients for other substances of abuse with return to Methadone Clinic

Board Questions  Is Methadone Maintenance consistent with our traditional drug free programming?  Is Methadone Maintenance more addicting?  How would this effect our reputation in the community?  How will we assure it is implemented correctly?

The Journey to Additional Paths to Recovery  Board Education to broaden their view of additional paths to recovery.  Satisfying board concerns in reference to safety and efficacy.  Soliciting a letter of support from the Board of Directors to for submission to licensing bodies.  Soliciting input and agreement from Medical and Psychiatric Staff

Barriers  Achieving Board approval  Staff acceptance  Multiple regulatory demands and limited resources  Development of policies and procedures for patient selection criteria  Development of an educational program to meet the needs of all

Successes  Achieved Letter of support from board  Developed policies and procedure for selection and medication protocols  Developed electronic learning primor with 85% completion rate  Developed and a role specific learning program and implementation underway  Ability to begin to expand our comprehensive services.  Application of request submitted to regulatory bodies October 2012

Next Steps  Looking forward to evolution of other medication assisted treatment modalities  Await regulatory approval  Continue and revisit round tables once program is implemented  Continue to evaluate current practice and look to streamline evidence based care as it applies to medication assisted treatment  Look to collaborate in best practice initiatives to support positive patient outcomes